JP2005508993A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508993A5
JP2005508993A5 JP2003543534A JP2003543534A JP2005508993A5 JP 2005508993 A5 JP2005508993 A5 JP 2005508993A5 JP 2003543534 A JP2003543534 A JP 2003543534A JP 2003543534 A JP2003543534 A JP 2003543534A JP 2005508993 A5 JP2005508993 A5 JP 2005508993A5
Authority
JP
Japan
Prior art keywords
valine
valaciclovir
protected
pure
valaciclovir hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003543534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508993A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/036269 external-priority patent/WO2003041647A2/en
Publication of JP2005508993A publication Critical patent/JP2005508993A/ja
Publication of JP2005508993A5 publication Critical patent/JP2005508993A5/ja
Withdrawn legal-status Critical Current

Links

JP2003543534A 2001-11-14 2002-11-13 バラシクロビルの合成及び精製 Withdrawn JP2005508993A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33280201P 2001-11-14 2001-11-14
US34227301P 2001-12-21 2001-12-21
PCT/US2002/036269 WO2003041647A2 (en) 2001-11-14 2002-11-13 Synthesis and purification of valacyclovir

Publications (2)

Publication Number Publication Date
JP2005508993A JP2005508993A (ja) 2005-04-07
JP2005508993A5 true JP2005508993A5 (https=) 2005-12-22

Family

ID=26988392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003543534A Withdrawn JP2005508993A (ja) 2001-11-14 2002-11-13 バラシクロビルの合成及び精製

Country Status (14)

Country Link
US (2) US6849737B2 (https=)
EP (1) EP1465894A4 (https=)
JP (1) JP2005508993A (https=)
KR (2) KR20070020149A (https=)
CN (1) CN1307177C (https=)
CA (2) CA2465928C (https=)
HR (1) HRP20040511A2 (https=)
IL (1) IL161969A0 (https=)
IN (1) IN2007DE04250A (https=)
IS (1) IS7260A (https=)
MX (1) MX242714B (https=)
NO (1) NO20042433L (https=)
PL (1) PL371732A1 (https=)
WO (1) WO2003041647A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2004446A3 (cs) * 2001-09-07 2005-01-12 Teva Pharmaceutical Industries Ltd. Krystalické formy valaciklovir hydrochloridu
WO2003040145A1 (en) * 2001-11-05 2003-05-15 Glaxo Group Limited Anhydrous crystal form of valaciclovir hydrochloride
CA2465928C (en) * 2001-11-14 2010-01-19 Teva Pharmaceutical Industries Ltd. Synthesis and purification of valacyclovir
US20050043329A1 (en) * 2002-09-06 2005-02-24 Shlomit Wizel Crystalline forms of valacyclovir hydrochloride
WO2004035583A1 (en) * 2002-10-16 2004-04-29 Teva Pharmaceutical Industries Ltd. Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
CA2548608A1 (en) * 2002-12-09 2004-06-24 Texcontor Etablissement Anhydrous crystalline form of valacyclovir hydrochloride
EP1633753A1 (en) * 2003-05-30 2006-03-15 EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. Novel crystalline forms of valacyclovir hydrochloride
TW200510414A (en) * 2003-06-02 2005-03-16 Teva Pharma Novel crystalline forms of valacyclovir hydrochloride
JP2007522130A (ja) * 2004-01-21 2007-08-09 テバ ファーマシューティカル インダストリーズ リミティド 塩酸バラシクロビルの調製方法
JP2008504255A (ja) * 2004-06-30 2008-02-14 テバ ファーマシューティカル インダストリーズ リミティド 結晶塩酸バラシクロビル中の残留アルコールを低減する方法
JP2007513074A (ja) * 2004-09-04 2007-05-24 テバ ファーマシューティカル インダストリーズ リミティド 単離されたバラシクロビル不純物、バラシクロビル不純物の調製方法および参照標準としての使用
US7958087B2 (en) * 2004-11-17 2011-06-07 Iron Mountain Incorporated Systems and methods for cross-system digital asset tag propagation
EP1746098A1 (en) * 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
US20070112193A1 (en) * 2005-11-14 2007-05-17 Khunt Mayur D Valacyclovir process
GB0605344D0 (en) * 2006-03-17 2006-04-26 Pliva Istrazivanje I Razvoj D Pharmaceutically acceptable salts and polymorphic forms
CN1903854B (zh) * 2006-08-09 2012-05-23 丽珠医药集团股份有限公司 一种合成盐酸伐昔洛韦的方法
WO2008139539A1 (ja) * 2007-04-27 2008-11-20 Ajinomoto Co., Inc. バラシクロビルの製造方法
US20080281099A1 (en) * 2007-05-07 2008-11-13 Mayur Devjibhai Khunt Process for purifying valacyclovir hydrochloride and intermediates thereof
CN102584825B (zh) * 2011-01-17 2014-04-02 四川科伦药物研究有限公司 一种合成盐酸伐昔洛韦的方法
WO2017149420A1 (en) * 2016-03-03 2017-09-08 Aurobindo Pharma Ltd Process for the preparation of valacyclovir
CN106632335A (zh) * 2016-12-27 2017-05-10 河南康达制药有限公司 一种盐酸伐昔洛韦的制备方法
CN114621227B (zh) * 2022-02-28 2024-07-09 海南久常制药有限公司 一种盐酸伐昔洛韦、制剂及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB8719367D0 (en) 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
DE69426880T2 (de) * 1993-06-10 2001-10-31 Rolabo S.L., Zaragoza Verfahren zur herstellung von aminosäureester von nukleosid analogen
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
GB9501178D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Guanine derivative
US6117453A (en) * 1995-04-14 2000-09-12 Pharma Pass Solid compositions containing polyethylene oxide and an active ingredient
US5672243A (en) * 1995-11-28 1997-09-30 Mosel Vitelic, Inc. Antireflection coating for highly reflective photolithographic layers comprising chromium oxide or chromium suboxide
EP0874631B1 (en) * 1996-01-19 2003-11-19 Glaxo Group Limited Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
US6040446A (en) * 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
IT1283447B1 (it) * 1996-07-18 1998-04-21 Ind Chimica Srl Processo di preparazione del valaciclovir e relativi intermedi
JP2001503767A (ja) * 1996-11-12 2001-03-21 メディヴィル・アクチボラグ ヌクレオシド
CZ2004446A3 (cs) * 2001-09-07 2005-01-12 Teva Pharmaceutical Industries Ltd. Krystalické formy valaciklovir hydrochloridu
WO2003040145A1 (en) * 2001-11-05 2003-05-15 Glaxo Group Limited Anhydrous crystal form of valaciclovir hydrochloride
CA2465928C (en) * 2001-11-14 2010-01-19 Teva Pharmaceutical Industries Ltd. Synthesis and purification of valacyclovir
WO2004000265A2 (en) * 2002-06-24 2003-12-31 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050043329A1 (en) * 2002-09-06 2005-02-24 Shlomit Wizel Crystalline forms of valacyclovir hydrochloride
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
WO2004035583A1 (en) * 2002-10-16 2004-04-29 Teva Pharmaceutical Industries Ltd. Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
CA2548608A1 (en) * 2002-12-09 2004-06-24 Texcontor Etablissement Anhydrous crystalline form of valacyclovir hydrochloride
EP1633753A1 (en) * 2003-05-30 2006-03-15 EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. Novel crystalline forms of valacyclovir hydrochloride
TW200510414A (en) * 2003-06-02 2005-03-16 Teva Pharma Novel crystalline forms of valacyclovir hydrochloride
JP2007522130A (ja) * 2004-01-21 2007-08-09 テバ ファーマシューティカル インダストリーズ リミティド 塩酸バラシクロビルの調製方法
US20060178512A1 (en) * 2005-02-04 2006-08-10 Cheruthur Govindan Method for preparing amino acid esters of nucleoside analogues
EP1746098A1 (en) * 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
US20070112193A1 (en) * 2005-11-14 2007-05-17 Khunt Mayur D Valacyclovir process
US20080281099A1 (en) * 2007-05-07 2008-11-13 Mayur Devjibhai Khunt Process for purifying valacyclovir hydrochloride and intermediates thereof

Similar Documents

Publication Publication Date Title
JP2005508993A5 (https=)
CA2465928A1 (en) Synthesis and purification of valacyclovir
AU2002344419C1 (en) Alpha-form or beta-form cyrstal of acetanilide derivative
HU193995B (en) Process for production of esther prodrug formations of derivatives of 3-hydroxi-morphinane formed with substituted bensoic acids and medical preparatives containing these compounds
US20110190267A1 (en) Prodrugs of opioids and uses thereof
RU2261860C2 (ru) ЗАМЕЩЕННЫЕ В ПОЛОЖЕНИИ 8А ПРОИЗВОДНЫЕ 8,8А-ДИГИДРОИНДЕНО [1,2-d] ТИАЗОЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ, НАПРИМЕР В КАЧЕСТВЕ АНОРЕКСИЧЕСКИХ СРЕДСТВ
IL192233A (en) Derivatives of N- (arylsulfonyl) beta-amino acids containing converted amino-methyl groups, for the preparation of a drug for the treatment of pain and inflammation
AU730369B2 (en) Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
CA2585983C (en) Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
CN105777664B (zh) 2‑(2‑苄亚肼基)噻唑‑5‑羧酸酯及其制备方法与医药用途
WO2015004599A1 (en) An improved process for preparing linagliptin and its key intermediates
JP2004531489A (ja) 抗炎症性および免疫抑制性活性を有する新規ベンズアミジン誘導体
CN107987033B (zh) 香草醛及其异构体在制备na抑制剂中的应用
CN108047160B (zh) 2-(2-苄亚肼基)-5-酰基噻唑及其医药用途
WO2001081331A1 (en) Hydrates and crystals of a neuraminic acid compound
JP2010501591A (ja) ３−（３−インドリル）プロピオン酸カルシウム塩およびそれから３−（３−インドリル）プロピオン酸の遊離酸を作る方法
CN109053606B (zh) 4-(4-羟基苯基亚甲氨基)-1,2,4-三唑-5-硫酮及其应用
CA2537132A1 (en) Amorphous valganciclovir hydrochloride
CN101781300B (zh) 一种恩替卡韦的盐化合物，其制备方法和药物应用
AU729421B2 (en) Guinidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
AU6514498A (en) 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 adrenoceptor agonists
EP2852592A1 (en) A process for the preparation of valacyclovir hydrochloride
CN101372487A (zh) 伐昔洛韦或其药学上可接受盐的制备
JPH05262770A (ja) 化学的製法
EP0710482B1 (en) Therapeutic agent for myocardial ischemic damages or reperfusion injuries